Author Correction: The current landscape of nucleic acid therapeutics.
2021
In Table 2 of the version of this Review originally published, the nucleic acid therapeutic ‘Nedosiran’ was incorrectly listed as a GalNAc– ASO conjugate, but it is a GalNAc–siRNA conjugate. Table 2 has now been amended accordingly in the online versions of the Review.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI